Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export

被引:178
作者
Evers, R
de Haas, M
Sparidans, R
Beijnen, J
Wielinga, PR
Lankelma, J
Borst, P
机构
[1] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands
[3] Slotervaart Hosp, Dept Pharm, NL-1066 EC Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Acad Hosp, Dept Med Oncol, NL-1007 MB Amsterdam, Netherlands
关键词
multidrug resistance protein; polarized cell; glutathione; organic anion; drug transport; GS-X pump;
D O I
10.1054/bjoc.2000.1262
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The multidrug resistance proteins MRP1 and MRP2 are members of the same subfamily of ATP-binding cassette transporters. Besides organic molecules conjugated to negatively charged ligands, these proteins also transport cytotoxic drugs for which no negatively charged conjugates are known to exist. In polarized MDCK[I cells. MRP1 routes to the lateral plasma membrane, and MRP2 to the apical plasma membrane. In these cells MRP1 transports daunorubicin, and MRP2 vinblastine; both transporters export reduced glutathione (GSH) into the medium. We demonstrate that glutathione transport in MDCKII-MRP1 cells is inhibited by the inhibitors of organic anion transporter; sulfinpyrazone, indomethacin, probenecid and benzbromarone. In MDCKII-MRP2 cells, GSH export is stimulated by row concentrations of sulfinpyrazone or indomethacin, whereas export is inhibited down to control revels at high concentrations. We find that unmodified sulfinpyrazone is a substrate for MRP2, also at concentrations where GSH export is inhibited. We also show that GSH export in MDGKII-MRP2 cells increases in the presence of vinblastine, and that the stochiometry between drug and GSH exported is between two and three. Our data indicate that transport of sulfinpyrazone and vinblastine is associated with GSH export. However, at high sulfinpyrazone concentrations this compound is transported without GSH, Models of MRP action are discussed that could explain these results. (C) 2000 Cancer Research Campaign.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 38 条
  • [1] Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain
    Bakos, E
    Evers, R
    Szakács, G
    Tusnády, GE
    Welker, E
    Szabó, K
    de Haas, M
    van Deemter, L
    Borst, P
    Váradi, A
    Sarkadi, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) : 32167 - 32175
  • [2] Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions
    Bakos, É
    Evers, R
    Sinkó, E
    Váradi, A
    Borst, P
    Sarkadi, B
    [J]. MOLECULAR PHARMACOLOGY, 2000, 57 (04) : 760 - 768
  • [3] Buchler M, 1996, J BIOL CHEM, V271, P15091
  • [4] Chu XY, 1997, CANCER RES, V57, P1934
  • [5] COLE SPC, 1994, CANCER RES, V54, P5902
  • [6] Cole SPC, 1998, BIOESSAYS, V20, P931, DOI 10.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO
  • [7] 2-J
  • [8] Cui YH, 1999, MOL PHARMACOL, V55, P929
  • [9] HEPATOBILIARY SECRETION OF ORGANIC-COMPOUNDS - MOLECULAR MECHANISMS OF MEMBRANE-TRANSPORT
    ELFERINK, RPJO
    MEIJER, DKF
    KUIPERS, F
    JANSEN, PLM
    GROEN, AK
    GROOTHUIS, GMM
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON BIOMEMBRANES, 1995, 1241 (02): : 215 - 268
  • [10] Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells
    Evers, R
    Zaman, GJR
    vanDeemter, L
    Jansen, H
    Calafat, J
    Oomen, LCJM
    Elferink, RPJO
    Borst, P
    Schinkel, AH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (05) : 1211 - 1218